Target intelligence / Profile preview

Salmonella Typhi outer membrane protein and flagellar protein (S. Typhi OMP and flagellar protein)

Target
S. Typhi OMP and flagellar protein
Molecular classification
Outer membrane protein (porin, nonporin OMP), Structural protein (flagellar protein), Other (efflux, transporter, antigenic protein)
01

Overview

Salmonella Typhi outer membrane proteins include a diverse set such as porins (e.g., OmpA, OmpC, OmpF) and nonporin proteins which are vital for bacterial nutrient uptake, antibiotic resistance, and interaction with the host immune system[1][3][7]. Notably, proteins like ST50 contribute to multi-drug efflux and have been identified as structural and antigenic components relevant for both bacterial survival and immunogenicity[5]. Flagellar proteins, such as flagellin, drive bacterial motility and are highly immunogenic, often serving as vaccine targets[3]. OMPs and flagellar proteins have overlapping roles in virulence, enabling host cell invasion, immune escape, and persistence; as such, they represent principal targets for vaccine and drug development. However, “S. Typhi outer membrane & flagellar proteins” is a broad collective descriptor—not a standardized target name—and should be refined to specify individual targets for structured analysis[3][5][1][6][7].

Other names
OMPsporinsnonporin outer membrane proteinsflagellin
02

Mechanism of action

Inhibition of efflux (blocks drug export through OMPs) Disruption of membrane structure and permeability (antibiotics, bile salts) Immunostimulation (vaccine-induced antibody targeting flagellin or OMPs)

03

Biological functions

Membrane permeability and nutrient uptakeAntibiotic resistance (multi-drug efflux)Virulence and host immune evasionMotility (flagella)
04

Disease associations

Infection (typhoid fever)Immune response and vaccine targetAntibiotic resistancePotential attenuation of virulence
05

Safety considerations

Antigenic cross-reactivity (OMPs are conserved between Gram-negative bacteria, leading to possible off-target immune responses)Resistance and adaptation (membrane protein mutations may confer drug resistance)Non-specific immune activation (flagellin is a potent immune stimulant)
06

Interacting drugs

Antimicrobial agents (targeting efflux proteins and membrane integrity, e.g., TolC inhibitors)

2 more in the full profile.

07

Biomarkers

Antigenicity in serological assays (OMPs, flagellin)OMP profile can be used to distinguish strains and monitor vaccine responses

Beyond the preview

Go deeper on Salmonella Typhi outer membrane protein and flagellar protein (S. Typhi OMP and flagellar protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella Typhi outer membrane protein and flagellar protein (S. Typhi OMP and flagellar protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call